Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,220,051
-$952,718 QoQ
Shares Held
12,522
-22.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#438
of 1,745 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vident Advisory, LLC holds $52,891,507 across 43 Biotechnology names. VRTX ranks #3 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
148,975 | $8,105,728 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
28,409 | $6,845,716 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
12,522 | $6,220,051 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,804 | $4,866,104 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
13,776 | $2,579,967 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
6,151 | $1,944,268 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,518 | $1,661,083 | |
| 8 | CYTK |
Cytokinetics Inc
|
15,898 | $1,354,349 |
All Filings in VRTX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,220,051 | 12,522 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $7,172,769 | 16,063 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,204,229 | 13,685 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $5,178,262 | 13,222 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,236,199 | 18,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,794,935 | 16,078 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,987,151 | 19,834 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,887,137 | 8,358 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,747,884 | 7,996 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $21,538,800 | 51,527 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $17,976,398 | 44,180 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,891,817 | 48,576 | Shares | Defined | 2024-02-21 | |
| No filing history on record for this holder in this stock. | ||||||